-
Argentina govt launches account to debunk 'lies' about Milei
-
Australia drug kingpin walks free after police informant scandal
-
Dupont wants more after France sparkle and then wobble against Ireland
-
Cuba says willing to talk to US, 'without pressure'
-
NFL names 49ers to face Rams in Aussie regular-season debut
-
Bielle-Biarrey sparkles as rampant France beat Ireland in Six Nations
-
Flame arrives in Milan for Winter Olympics ceremony
-
Olympic big air champion Su survives scare
-
89 kidnapped Nigerian Christians released
-
Cuba willing to talk to US, 'without pressure'
-
Famine spreading in Sudan's Darfur, UN-backed experts warn
-
2026 Winter Olympics flame arrives in Milan
-
Congo-Brazzaville's veteran president declares re-election run
-
Olympic snowboard star Chloe Kim proud to represent 'diverse' USA
-
Iran filmmaker Panahi fears Iranians' interests will be 'sacrificed' in US talks
-
Leicester at risk of relegation after six-point deduction
-
Deadly storm sparks floods in Spain, raises calls to postpone Portugal vote
-
Trump urges new nuclear treaty after Russia agreement ends
-
'Burned in their houses': Nigerians recount horror of massacre
-
Carney scraps Canada EV sales mandate, affirms auto sector's future is electric
-
Emotional reunions, dashed hopes as Ukraine soldiers released
-
Bad Bunny promises to bring Puerto Rican culture to Super Bowl
-
Venezuela amnesty bill excludes gross rights abuses under Chavez, Maduro
-
Lower pollution during Covid boosted methane: study
-
Doping chiefs vow to look into Olympic ski jumping 'penis injection' claims
-
England's Feyi-Waboso in injury scare ahead of Six Nations opener
-
EU defends Spain after Telegram founder criticism
-
Novo Nordisk vows legal action to protect Wegovy pill
-
Swiss rivalry is fun -- until Games start, says Odermatt
-
Canadian snowboarder McMorris eyes slopestyle after crash at Olympics
-
Deadly storm sparks floods in Spain, disrupts Portugal vote
-
Ukrainian flag bearer proud to show his country is still standing
-
Carney scraps Canada EV sales mandate
-
Morocco says evacuated 140,000 people due to severe weather
-
Spurs boss Frank says Romero outburst 'dealt with internally'
-
Giannis suitors make deals as NBA trade deadline nears
-
Carrick stresses significance of Munich air disaster to Man Utd history
-
Record January window for transfers despite drop in spending
-
'Burned inside their houses': Nigerians recount horror of massacre
-
Iran, US prepare for Oman talks after deadly protest crackdown
-
Winter Olympics opening ceremony nears as virus disrupts ice hockey
-
Mining giant Rio Tinto abandons Glencore merger bid
-
Davos forum opens probe into CEO Brende's Epstein links
-
ECB warns of stronger euro impact, holds rates
-
Famine spreading in Sudan's Darfur, warn UN-backed experts
-
Lights back on in eastern Cuba after widespread blackout
-
Russia, US agree to resume military contacts at Ukraine talks
-
Greece aims to cut queues at ancient sites with new portal
-
No time frame to get Palmer in 'perfect' shape - Rosenior
-
Stocks fall as tech valuation fears stoke volatility
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
Z.AlNajjar--SF-PST